[{"AdditionalPaidInCapital_0_Q2_USD":5071799.0,"ProceedsFromNotesPayable_2_Q2_USD":300000.0,"SharesIssuedPricePerShare_0_Q2_USD":10.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":430459.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":11.5,"PrepaidExpenseCurrent_0_Q2_USD":430459.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1_Q2_USD":16400000.0,"ProceedsFromIssuanceOfWarrants_2_Q2_USD":16400000.0,"SharePrice_0_Q2_USD":9.2,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":783843654.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":42464.0,"RepaymentsOfRelatedPartyDebt_2_Q2_USD":17631.0,"PreferredStockValue_0_Q2_USD":0.0,"CashFDICInsuredAmount_0_Q2_USD":250000.0,"InvestmentIncomeInterest_1_Q2_USD":64246.0,"RepaymentsOfNotesPayable_2_Q2_USD":300000.0,"RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_2_Q2_USD":20000.0,"RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1_Q2_USD":20000.0,"OtherDeferredCostsNet_0_Q2_USD":776346.0,"BusinessCombinationConsiderationTransferred1_2_Q2_USD":2898000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":750542.0,"CostOfTrustAssetsSoldToPayExpenses_2_Q2_USD":100000.0,"PaymentOfFinancingAndStockIssuanceCosts_2_Q2_USD":748021.0,"SaleOfStockNumberOfSharesIssuedInTransaction_2_Q2_shares":82800000.0,"TemporaryEquityNetIncome_2_Q2_USD":-61695.0,"InvestmentIncomeInterest_2_Q2_USD":64246.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":38533333.0,"Assets_0_Q2_USD":829245247.0,"AssetsCurrent_0_Q2_USD":1181001.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":750542.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.01,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.01,"Liabilities_0_Q2_USD":29050789.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":829245247.0,"LiabilitiesCurrent_0_Q2_USD":70789.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":829259348.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-828000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-508806.0,"NetIncomeLoss_2_Q2_USD":-56565.0,"NetIncomeLoss_1_Q2_USD":-56565.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":25000.0,"ProfitLoss_2_Q2_USD":-56565.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-74196.0,"StockholdersEquity_0_Q2_USD":5000002.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":18221528.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":22399101.0,"AccruedLiabilitiesCurrent_0_Q2_USD":42464.0,"CommitmentsAndContingencies_0_Q2_USD":null,"OperatingIncomeLoss_2_Q2_USD":-120811.0,"OperatingIncomeLoss_1_Q2_USD":-120811.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"TemporaryEquityNetIncome_1_Q2_USD":-61695.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":79513276.0,"Ticker":"CLOV","CIK":"1801170","name":"SOCIAL CAPITAL HEDOSOPHIA HOLDINGS CORP. III","OfficialName":"Clover Health Investments Corp. Class A Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1335321000.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20200813"}]